Carbon, ISSN 0008-6223, 11/2014, Volume 78, pp. 589 - 600
In Double-Walled-Carbon-Nanotubes (DWCNTs) the outer shell screens the inner one from the external environment. As a consequence, the electronic properties of...
METALLIC IMPURITIES | ELECTROCHEMISTRY | OXIDATION | INTERFACING NEURONS | APOPTOSIS | STIMULATION | NEURONAL GROWTH | MATERIALS SCIENCE, MULTIDISCIPLINARY | ELECTRODES | CHEMISTRY, PHYSICAL | CCVD SYNTHESIS | HYPOXIA | Cancer cells | Colorectal cancer | Nanotubes | Cancer | Carbon nanotubes | Nanostructure | Biological | Carbon | Electrode potentials | Walls | Tumors | Engineering Sciences | Materials
METALLIC IMPURITIES | ELECTROCHEMISTRY | OXIDATION | INTERFACING NEURONS | APOPTOSIS | STIMULATION | NEURONAL GROWTH | MATERIALS SCIENCE, MULTIDISCIPLINARY | ELECTRODES | CHEMISTRY, PHYSICAL | CCVD SYNTHESIS | HYPOXIA | Cancer cells | Colorectal cancer | Nanotubes | Cancer | Carbon nanotubes | Nanostructure | Biological | Carbon | Electrode potentials | Walls | Tumors | Engineering Sciences | Materials
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 2008, Volume 100, Issue 4, pp. 343 - 350
Background Sublingual immunotherapy (SLIT) is safe and efficacious in the treatment of patients with allergic rhinitis. Although favorable clinical effects...
Allergy and Immunology | ANTIBODIES | RHINITIS | ROUTES | ALLERGY | IMMUNE-RESPONSES | DECREASE | SYSTEMIC IMMUNOLOGICAL CHANGES | MITES | PARAMETERS | HEALTHY | IMMUNOLOGY | CHILDREN | Transforming Growth Factor beta - immunology | Poaceae - immunology | Immunotherapy - methods | Administration, Sublingual | Lymphocyte Activation | Humans | Middle Aged | Interleukin-10 - blood | Male | Transforming Growth Factor beta - blood | Rhinitis, Allergic, Seasonal - immunology | Plant Extracts - administration & dosage | Allergens - administration & dosage | Rhinitis, Allergic, Seasonal - therapy | Pilot Projects | Flow Cytometry | Allergens - immunology | Statistics, Nonparametric | Adult | Female | Interleukin-10 - biosynthesis | T-Lymphocytes - immunology | Plant Extracts - immunology | Interleukin-10 - immunology
Allergy and Immunology | ANTIBODIES | RHINITIS | ROUTES | ALLERGY | IMMUNE-RESPONSES | DECREASE | SYSTEMIC IMMUNOLOGICAL CHANGES | MITES | PARAMETERS | HEALTHY | IMMUNOLOGY | CHILDREN | Transforming Growth Factor beta - immunology | Poaceae - immunology | Immunotherapy - methods | Administration, Sublingual | Lymphocyte Activation | Humans | Middle Aged | Interleukin-10 - blood | Male | Transforming Growth Factor beta - blood | Rhinitis, Allergic, Seasonal - immunology | Plant Extracts - administration & dosage | Allergens - administration & dosage | Rhinitis, Allergic, Seasonal - therapy | Pilot Projects | Flow Cytometry | Allergens - immunology | Statistics, Nonparametric | Adult | Female | Interleukin-10 - biosynthesis | T-Lymphocytes - immunology | Plant Extracts - immunology | Interleukin-10 - immunology
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 2013, Volume 75, Issue 2, pp. 130 - 134
Abstract We examined the performance of a real-time polymerase chain reaction (PCR) test (Septi Fast ) for early detection of bloodstream infection in febrile...
Infectious Disease | Internal Medicine | Neutropaenia | Haematologic cancer patient | Bloodstream infection | Blood culture | PCR | Antibiotic therapy | DIAGNOSIS | INFECTIOUS DISEASES | FUNGAL PATHOGENS | MICROBIOLOGY | SEPSIS | BACTERIAL | CULTURE | CANCER-PATIENTS | FEBRILE NEUTROPENIA | PCR ASSAY | Fever - microbiology | Humans | Real-Time Polymerase Chain Reaction - methods | Fungi - isolation & purification | Bacteremia - diagnosis | Fungemia - blood | Fungemia - microbiology | Bacteria - genetics | Fungemia - diagnosis | Fungi - genetics | Bacteremia - microbiology | Myeloproliferative Disorders - blood | Bacteria - isolation & purification | Myeloproliferative Disorders - microbiology | Neutropenia - microbiology | Sensitivity and Specificity | Bacteremia - blood | Polymerase chain reaction | Medical examination | Health aspects | Methods | Blood
Infectious Disease | Internal Medicine | Neutropaenia | Haematologic cancer patient | Bloodstream infection | Blood culture | PCR | Antibiotic therapy | DIAGNOSIS | INFECTIOUS DISEASES | FUNGAL PATHOGENS | MICROBIOLOGY | SEPSIS | BACTERIAL | CULTURE | CANCER-PATIENTS | FEBRILE NEUTROPENIA | PCR ASSAY | Fever - microbiology | Humans | Real-Time Polymerase Chain Reaction - methods | Fungi - isolation & purification | Bacteremia - diagnosis | Fungemia - blood | Fungemia - microbiology | Bacteria - genetics | Fungemia - diagnosis | Fungi - genetics | Bacteremia - microbiology | Myeloproliferative Disorders - blood | Bacteria - isolation & purification | Myeloproliferative Disorders - microbiology | Neutropenia - microbiology | Sensitivity and Specificity | Bacteremia - blood | Polymerase chain reaction | Medical examination | Health aspects | Methods | Blood
Journal Article
Lecture Notes in Electrical Engineering, ISSN 1876-1100, 2017, Volume 409, pp. 1 - 7
Journal Article
Antiviral therapy, 2017, Volume 22, Issue 4, p. 365
Direct-acting antiviral (DAA) combinations are potent and effective drugs currently recommended for treatment of chronic HCV infection. Difficult to treat...
Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Reassortant Viruses - genetics | Reassortant Viruses - drug effects | Alanine Transaminase - blood | Phylogeny | Treatment Failure | Female | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Reassortant Viruses - growth & development | Drug Resistance, Viral - genetics | Liver Cirrhosis - virology | Sequence Analysis, RNA | Hepacivirus - growth & development | Italy | Hepacivirus - classification | Drug Combinations | Reassortant Viruses - classification
Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Reassortant Viruses - genetics | Reassortant Viruses - drug effects | Alanine Transaminase - blood | Phylogeny | Treatment Failure | Female | Hepacivirus - drug effects | Sofosbuvir - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Reassortant Viruses - growth & development | Drug Resistance, Viral - genetics | Liver Cirrhosis - virology | Sequence Analysis, RNA | Hepacivirus - growth & development | Italy | Hepacivirus - classification | Drug Combinations | Reassortant Viruses - classification
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 3/2010, Volume 65, Issue 3, pp. 425 - 433
Objectives To understand the dynamic viral evolution observed during failure on raltegravir-containing regimens, we studied the genotypic and phenotypic...
Replication capacity | Isentress | Fitness | INFECTIOUS DISEASES | SENSITIVITY | MICROBIOLOGY | EVOLUTION | GENE | PLASMA-LEVELS | fitness | MK-0518 | IMMUNODEFICIENCY-VIRUS TYPE-1 | PHARMACOLOGY & PHARMACY | replication capacity | MUTATIONS | INHIBITOR | VARIANTS RESISTANT | Anti-HIV Agents - pharmacology | HIV-1 - drug effects | HIV Infections - virology | Humans | Cells, Cultured | Drug Resistance, Viral | Genotype | Mutation, Missense | HIV-1 - genetics | Sequence Analysis, DNA | Microbial Sensitivity Tests | Phenotype | HIV Integrase - genetics | Virus Replication | HIV-1 - isolation & purification | Pyrrolidinones - pharmacology | Inhibitory Concentration 50 | Amino Acid Substitution - genetics | HIV Infections - drug therapy | CD4-Positive T-Lymphocytes - virology | Raltegravir Potassium
Replication capacity | Isentress | Fitness | INFECTIOUS DISEASES | SENSITIVITY | MICROBIOLOGY | EVOLUTION | GENE | PLASMA-LEVELS | fitness | MK-0518 | IMMUNODEFICIENCY-VIRUS TYPE-1 | PHARMACOLOGY & PHARMACY | replication capacity | MUTATIONS | INHIBITOR | VARIANTS RESISTANT | Anti-HIV Agents - pharmacology | HIV-1 - drug effects | HIV Infections - virology | Humans | Cells, Cultured | Drug Resistance, Viral | Genotype | Mutation, Missense | HIV-1 - genetics | Sequence Analysis, DNA | Microbial Sensitivity Tests | Phenotype | HIV Integrase - genetics | Virus Replication | HIV-1 - isolation & purification | Pyrrolidinones - pharmacology | Inhibitory Concentration 50 | Amino Acid Substitution - genetics | HIV Infections - drug therapy | CD4-Positive T-Lymphocytes - virology | Raltegravir Potassium
Journal Article
New Microbiologica, ISSN 1121-7138, 01/2015, Volume 38, Issue 1, pp. 91 - 95
The identification of a putative novel type human papillomaviruses (HPV) strain related to HPV-RTRX3 in a subject with penile skin warts and glans lichen...
Journal Article
Journal of Hepatology, ISSN 0168-8278, 12/2019, Volume 71, Issue 6, pp. 1106 - 1115
Sofosbuvir/velpatasivr/voxilaprevir (SOF/VEL/VOX) is approved for retreatment of patients with HCV and a previous failure on direct-acting antivirals (DAAs),...
Resistance | Retreatment | HCV | RAS | Sofosbuvir | Direct-acting antivirals | VIRUS-INFECTION | RIBAVIRIN | REGIMENS | THERAPY | NS5A | SOFOSBUVIR-VELPATASVIR-VOXILAPREVIR | EXPERIENCED PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | GLECAPREVIR/PIBRENTASVIR
Resistance | Retreatment | HCV | RAS | Sofosbuvir | Direct-acting antivirals | VIRUS-INFECTION | RIBAVIRIN | REGIMENS | THERAPY | NS5A | SOFOSBUVIR-VELPATASVIR-VOXILAPREVIR | EXPERIENCED PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | GLECAPREVIR/PIBRENTASVIR
Journal Article
Nature (London), ISSN 0028-0836, 11/2014, Volume 522, Issue 7554
Nature 522, 68-72 (04 June 2015) A joint measurement is presented of the branching fractions $B^0_s\to\mu^+\mu^-$ and $B^0\to\mu^+\mu^-$ in proton-proton...
experimental particle physics | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS
experimental particle physics | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS
Journal Article
Journal of General Virology, ISSN 0022-1317, 04/2012, Volume 93, Issue 4, pp. 889 - 899
Human immunodeficiency virus type 2 (HIV-2) emerged in West Africa and has spread further to countries that share socio-historical ties with this region....
ORIGIN | VIROLOGY | GUINEA-BISSAU | COTE-DIVOIRE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | HIV-2 INFECTION | RESISTANCE MUTATIONS | PREVALENCE | EPIDEMIC | SPREAD | IDENTIFICATION | SUBTYPE-B | Genome, Viral - genetics | HIV Infections - history | HIV Infections - virology | History, 20th Century | Humans | Phylogeography | Cote d'Ivoire | Molecular Sequence Data | Colonialism - history | Guinea-Bissau | Genes, Viral - genetics | Senegal | Bayes Theorem | HIV-2 - genetics | Cabo Verde | Africa, Western | Animal | Standard
ORIGIN | VIROLOGY | GUINEA-BISSAU | COTE-DIVOIRE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | HIV-2 INFECTION | RESISTANCE MUTATIONS | PREVALENCE | EPIDEMIC | SPREAD | IDENTIFICATION | SUBTYPE-B | Genome, Viral - genetics | HIV Infections - history | HIV Infections - virology | History, 20th Century | Humans | Phylogeography | Cote d'Ivoire | Molecular Sequence Data | Colonialism - history | Guinea-Bissau | Genes, Viral - genetics | Senegal | Bayes Theorem | HIV-2 - genetics | Cabo Verde | Africa, Western | Animal | Standard
Journal Article
Retrovirology, ISSN 1742-4690, 05/2010, Volume 7, Issue S1, pp. O16 - O16
Journal Article
92.
Full Text
Use of a CMOS Image Sensor for an Active Personal Dosimeter in Interventional Radiology
IEEE Transactions on Instrumentation and Measurement, ISSN 0018-9456, 05/2013, Volume 62, Issue 5, pp. 1065 - 1072
Interventional radiologists and staff members, during all their professional activities, are frequently exposed to protracted and fractionated low doses of...
Active Personal Dosimeter | Uncertainty | dosimetry | Measurement uncertainty | Noise | Clustering algorithms | CMOS pixels | Time measurement | Electron tubes | X-ray | interventional radiology (IR) | Photonics | INSTRUMENTS & INSTRUMENTATION | ENGINEERING, ELECTRICAL & ELECTRONIC | Technology application | Dosimeters | Usage | Radiology | Radiology, Medical | Research | Complementary metal oxide semiconductors
Active Personal Dosimeter | Uncertainty | dosimetry | Measurement uncertainty | Noise | Clustering algorithms | CMOS pixels | Time measurement | Electron tubes | X-ray | interventional radiology (IR) | Photonics | INSTRUMENTS & INSTRUMENTATION | ENGINEERING, ELECTRICAL & ELECTRONIC | Technology application | Dosimeters | Usage | Radiology | Radiology, Medical | Research | Complementary metal oxide semiconductors
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2012, Volume 8, Issue 3, pp. 299 - 307
Abstract Aiming to explore the mechanisms modulating cell-carbon nanotube interactions, we investigated whether Ca2+ ion balancing between intra- and...
Internal Medicine | Carbon nanotubes | Calcium balancing | MWCNTs | Intracellular Ca2+ mobilization | mobilization | Intracellular Ca | MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | MECHANISM | MACROPHAGES | NANOSCIENCE & NANOTECHNOLOGY | TOXICITY | MICROSCOPY | INFLUX | CELL-LINE | Electrochemical Techniques | Calcium - metabolism | Nanotechnology - methods | Humans | Intercellular Junctions - metabolism | Rats | Ions | Electric Conductivity | Electric Impedance | Platelet-Rich Plasma - metabolism | Platelet Aggregation | Animals | Nanotubes, Carbon - chemistry | Cell Shape | Intracellular Space - metabolism | Cell Line, Tumor | Tin Compounds - chemistry | Electrons | Ethylene glycol | Nanotubes | Adenocarcinoma | Calcium (intracellular) | Calcium | Platelet aggregation | Carbon | Aromatics | Sorption | nanotubes | nanotechnology | Chelating agents | Colon | Condensed Matter | Materials Science | Physics
Internal Medicine | Carbon nanotubes | Calcium balancing | MWCNTs | Intracellular Ca2+ mobilization | mobilization | Intracellular Ca | MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | MECHANISM | MACROPHAGES | NANOSCIENCE & NANOTECHNOLOGY | TOXICITY | MICROSCOPY | INFLUX | CELL-LINE | Electrochemical Techniques | Calcium - metabolism | Nanotechnology - methods | Humans | Intercellular Junctions - metabolism | Rats | Ions | Electric Conductivity | Electric Impedance | Platelet-Rich Plasma - metabolism | Platelet Aggregation | Animals | Nanotubes, Carbon - chemistry | Cell Shape | Intracellular Space - metabolism | Cell Line, Tumor | Tin Compounds - chemistry | Electrons | Ethylene glycol | Nanotubes | Adenocarcinoma | Calcium (intracellular) | Calcium | Platelet aggregation | Carbon | Aromatics | Sorption | nanotubes | nanotechnology | Chelating agents | Colon | Condensed Matter | Materials Science | Physics
Journal Article
Bioelectrochemistry, ISSN 1567-5394, 06/2012, Volume 85, pp. 21 - 28
Mitochondrial respiration generates reactive oxygen species that are involved in physiological and pathological processes. The majority of methods, with...
Amperometry | Mitochondria | Platinized carbon fiber microelectrodes | Hydrogen peroxide | ELECTROCHEMISTRY | RESPIRATORY-CHAIN | OXYGEN SPECIES PRODUCTION | OXIDATIVE STRESS | SUPEROXIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | RELEASE | REACTIVE OXYGEN | BIOPHYSICS | COMPLEX-I | BIOLOGY | NITRIC-OXIDE | GENERATION | REAL-TIME | Animals | Reactive Oxygen Species - metabolism | Cell Respiration | Energy Metabolism | Oxidation-Reduction | Liver - metabolism | Oxygen Consumption | Electrochemical Techniques - methods | Mice | Mitochondria - metabolism | Hydrogen Peroxide - metabolism | Physiological aspects | Cyanides | Superoxide | Mitochondrial DNA | Peroxides | Chemical properties
Amperometry | Mitochondria | Platinized carbon fiber microelectrodes | Hydrogen peroxide | ELECTROCHEMISTRY | RESPIRATORY-CHAIN | OXYGEN SPECIES PRODUCTION | OXIDATIVE STRESS | SUPEROXIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | RELEASE | REACTIVE OXYGEN | BIOPHYSICS | COMPLEX-I | BIOLOGY | NITRIC-OXIDE | GENERATION | REAL-TIME | Animals | Reactive Oxygen Species - metabolism | Cell Respiration | Energy Metabolism | Oxidation-Reduction | Liver - metabolism | Oxygen Consumption | Electrochemical Techniques - methods | Mice | Mitochondria - metabolism | Hydrogen Peroxide - metabolism | Physiological aspects | Cyanides | Superoxide | Mitochondrial DNA | Peroxides | Chemical properties
Journal Article
The Journal of Physical Chemistry B, ISSN 1520-6106, 02/2006, Volume 110, Issue 5, pp. 2241 - 2248
Cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and digital simulation techniques were used to investigate quantitatively the mechanism...
SCANNING ELECTROCHEMICAL MICROSCOPY | GLUCOSE-OXIDASE | MOLECULAR FILMS | CHEMISTRY, PHYSICAL | PHASE ELEMENT BEHAVIOR | MULTILAYER ENZYME ELECTRODE | CYCLIC VOLTAMMETRY | CHARGE-TRANSFER | THIOL MONOLAYERS | ALKANETHIOL MONOLAYERS | SURFACES
SCANNING ELECTROCHEMICAL MICROSCOPY | GLUCOSE-OXIDASE | MOLECULAR FILMS | CHEMISTRY, PHYSICAL | PHASE ELEMENT BEHAVIOR | MULTILAYER ENZYME ELECTRODE | CYCLIC VOLTAMMETRY | CHARGE-TRANSFER | THIOL MONOLAYERS | ALKANETHIOL MONOLAYERS | SURFACES
Journal Article
Current HIV Research, ISSN 1570-162X, 2011, Volume 9, Issue 1, pp. 17 - 22
Viral population in a long term non progressor carrying CRF02-AG HIV-1 virus variants with a truncated RT gene and attenuated virus replication was analyzed....
HIV-1 | Slow progressor | Viral complementation | Pol mutations | Defective variants | Viral replication | RT stop codons | defective variants | INFECTIOUS DISEASES | LONG-TERM SURVIVORS | slow progressor | REVERSE-TRANSCRIPTASE | viral complementation | MECHANISMS | pol mutations | IMMUNOLOGY | VIROLOGICAL RESPONSE | viral replication | REPLICATION | VIROLOGY | COMPLEMENTATION | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | MUTATIONS | NONPROGRESSOR | Amino Acid Sequence | Sequence Deletion | HIV-1 - pathogenicity | HIV Infections - virology | Humans | Cells, Cultured | DNA, Viral - isolation & purification | Molecular Sequence Data | HIV Reverse Transcriptase - genetics | Male | HIV Reverse Transcriptase - deficiency | Codon, Nonsense | HIV Long-Term Survivors | HIV-1 - genetics | Leukocytes, Mononuclear - virology | Sequence Analysis, DNA | RNA, Viral - genetics | Virus Replication | Adult | HIV-1 - enzymology | DNA, Viral - genetics | RNA, Viral - isolation & purification
HIV-1 | Slow progressor | Viral complementation | Pol mutations | Defective variants | Viral replication | RT stop codons | defective variants | INFECTIOUS DISEASES | LONG-TERM SURVIVORS | slow progressor | REVERSE-TRANSCRIPTASE | viral complementation | MECHANISMS | pol mutations | IMMUNOLOGY | VIROLOGICAL RESPONSE | viral replication | REPLICATION | VIROLOGY | COMPLEMENTATION | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | MUTATIONS | NONPROGRESSOR | Amino Acid Sequence | Sequence Deletion | HIV-1 - pathogenicity | HIV Infections - virology | Humans | Cells, Cultured | DNA, Viral - isolation & purification | Molecular Sequence Data | HIV Reverse Transcriptase - genetics | Male | HIV Reverse Transcriptase - deficiency | Codon, Nonsense | HIV Long-Term Survivors | HIV-1 - genetics | Leukocytes, Mononuclear - virology | Sequence Analysis, DNA | RNA, Viral - genetics | Virus Replication | Adult | HIV-1 - enzymology | DNA, Viral - genetics | RNA, Viral - isolation & purification
Journal Article
ChemMedChem, ISSN 1860-7179, 08/2011, Volume 6, Issue 8, pp. 1371 - 1389
A hit optimization protocol applied to the first nonnucleoside inhibitor of the ATPase activity of human DEAD‐box RNA helicase DDX3 led to the design and...
inhibitors | HIV‐1 | host cofactors | helicase | DDX3 | antiviral agents | HIV-1 | Antiviral agents | Helicase | Host cofactors | Inhibitors | CHEMISTRY, MEDICINAL | ANALOGS | NUCLEOSIDE | REPLICATION | BOX RNA HELICASE | PHARMACOLOGY & PHARMACY | INFECTION | KNOCKDOWN | Anti-HIV Agents - toxicity | Rhodanine - chemical synthesis | Humans | MicroRNAs - metabolism | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | Triazines - toxicity | Anti-HIV Agents - chemical synthesis | Gene Knockdown Techniques | DEAD-box RNA Helicases - antagonists & inhibitors | Computer Simulation | Enzyme Inhibitors - chemistry | Enzyme Inhibitors - toxicity | Drug Design | Triazines - chemistry | DEAD-box RNA Helicases - metabolism | Drug Evaluation, Preclinical | Virus Replication - drug effects | HIV-1 - drug effects | Rhodanine - chemistry | DEAD-box RNA Helicases - genetics | Anti-HIV Agents - chemistry | Rhodanine - toxicity | Triazines - chemical synthesis | Cell Line, Tumor | HIV-1 - enzymology | Drug Screening Assays, Antitumor
inhibitors | HIV‐1 | host cofactors | helicase | DDX3 | antiviral agents | HIV-1 | Antiviral agents | Helicase | Host cofactors | Inhibitors | CHEMISTRY, MEDICINAL | ANALOGS | NUCLEOSIDE | REPLICATION | BOX RNA HELICASE | PHARMACOLOGY & PHARMACY | INFECTION | KNOCKDOWN | Anti-HIV Agents - toxicity | Rhodanine - chemical synthesis | Humans | MicroRNAs - metabolism | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | Triazines - toxicity | Anti-HIV Agents - chemical synthesis | Gene Knockdown Techniques | DEAD-box RNA Helicases - antagonists & inhibitors | Computer Simulation | Enzyme Inhibitors - chemistry | Enzyme Inhibitors - toxicity | Drug Design | Triazines - chemistry | DEAD-box RNA Helicases - metabolism | Drug Evaluation, Preclinical | Virus Replication - drug effects | HIV-1 - drug effects | Rhodanine - chemistry | DEAD-box RNA Helicases - genetics | Anti-HIV Agents - chemistry | Rhodanine - toxicity | Triazines - chemical synthesis | Cell Line, Tumor | HIV-1 - enzymology | Drug Screening Assays, Antitumor
Journal Article
Minerva ginecologica, 02/2016, Volume 68, Issue 1, p. 21
The aim of this paper was to assess the accuracy of frozen sections histological examination and preoperative CA-125 to select patients with high risk...
Predictive Value of Tests | Frozen Sections | CA-125 Antigen - blood | Humans | Middle Aged | Risk Factors | Hysterectomy - methods | Patient Selection | Algorithms | Sensitivity and Specificity | Endometrial Neoplasms - surgery | Aged, 80 and over | Adult | Endometrial Neoplasms - pathology | Female | Aged | Retrospective Studies | Neoplasm Staging
Predictive Value of Tests | Frozen Sections | CA-125 Antigen - blood | Humans | Middle Aged | Risk Factors | Hysterectomy - methods | Patient Selection | Algorithms | Sensitivity and Specificity | Endometrial Neoplasms - surgery | Aged, 80 and over | Adult | Endometrial Neoplasms - pathology | Female | Aged | Retrospective Studies | Neoplasm Staging
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 5/2009, Volume 48, Issue 9, pp. 1310 - 1317
Background, There is currently an experts' agreement discouraging interruption of antiretroviral treatment (ART) during the first trimester of pregnancy in...
Pregnancy | HIV/AIDS | Antiretrovirals | Pediatrics | Highly active antiretroviral therapy | First trimester of pregnancy | Third trimester of pregnancy | Children | Viral load | Assisted reproductive techniques | HIV 1 | VIRAL LOAD | INFECTIOUS DISEASES | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | MATERNAL-INFANT TRANSMISSION | COMBINATION | WOMEN | PROPHYLAXIS | THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | VERTICAL TRANSMISSION | Prospective Studies | Humans | Risk Factors | Infectious Disease Transmission, Vertical | Withholding Treatment | Pregnancy Trimester, First | Pregnancy Trimester, Third | Viral Load | Delivery, Obstetric | HIV-1 - isolation & purification | Pregnancy Complications, Infectious - drug therapy | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - transmission | Infant, Newborn | Cohort Studies | Antiviral agents | Perinatal infection | Demographic aspects | Dosage and administration | Research | HIV infection | Risk factors
Pregnancy | HIV/AIDS | Antiretrovirals | Pediatrics | Highly active antiretroviral therapy | First trimester of pregnancy | Third trimester of pregnancy | Children | Viral load | Assisted reproductive techniques | HIV 1 | VIRAL LOAD | INFECTIOUS DISEASES | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | MATERNAL-INFANT TRANSMISSION | COMBINATION | WOMEN | PROPHYLAXIS | THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | INFECTION | VERTICAL TRANSMISSION | Prospective Studies | Humans | Risk Factors | Infectious Disease Transmission, Vertical | Withholding Treatment | Pregnancy Trimester, First | Pregnancy Trimester, Third | Viral Load | Delivery, Obstetric | HIV-1 - isolation & purification | Pregnancy Complications, Infectious - drug therapy | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - transmission | Infant, Newborn | Cohort Studies | Antiviral agents | Perinatal infection | Demographic aspects | Dosage and administration | Research | HIV infection | Risk factors
Journal Article